CSL stock: Citi keeps target at AUD 180.00 for CSL stock

Published on 10/20/2026 at 16:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CSL reported USD 15.8 billion revenue in fiscal year 2026. CSL stock costs EUR 121.31 at Lang & Schwarz on October 20, 2026.

Target and results in view

Citi maintained a Hold rating and set an AUD 180.00 target on October 20, 2026.
CSL reported USD 15.8 billion in fiscal year 2026 revenue.
CSL stock costs EUR 121.31 at Lang & Schwarz on October 20, 2026 at 4:40 p.m. CEST.

CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL (AU000000CSL8) received a Hold rating and an AUD 180.00 price target from Citi on October 20, 2026, while the stock was quoted at EUR 121.31 at Lang & Schwarz at 4:40 p.m. CEST. The target adds a fresh analyst reference as investors assess the group's recovery after its fiscal year 2026 results.

Citi sets a measured target

According to TipRanks, Citi maintained its Hold rating and set the AUD 180.00 target in a report released on October 20, 2026. The same report placed CSL alongside other healthcare coverage, making the target a direct valuation marker rather than a change to company guidance.

Revenue fell in fiscal year 2026

CSL's latest reported financial picture remains mixed. The Motley Fool Australia reported that fiscal year 2026 revenue reached USD 15.8 billion and net profit after tax was USD 2.6 billion. The report said the result came ahead of guidance and that management expected a return to growth in fiscal year 2027.

Price position and valuation

On the ASX, CSL last traded at AUD 196.30 on October 20, 2026 at 4:11 p.m. AEDT, against an AUD 194.05 previous session close. The quoted 52-week range was AUD 90.00 to AUD 221.76, placing the share price AUD 25.46 below its high and AUD 106.30 above its low. Trading volume reached 1,232,168 shares on the same date.

The finance profile put CSL's market capitalization at AUD 94.2 billion as of October 20, 2026. Its valuation remains sensitive to the earnings recovery described by management and to execution in the CSL Behring business, while Citi's AUD 180.00 target sits below the ASX quotation of AUD 196.30.

Dates for CSL shareholders

CSL's annual general meeting is scheduled for October 27, 2026, according to the company's investor-relations page. The meeting will be held in Melbourne and will also offer online participation. That date gives shareholders the next scheduled corporate checkpoint after the fiscal year 2026 reporting cycle.

What the target means for CSL

Citi's Hold rating and AUD 180.00 target contrast with the AUD 196.30 ASX quotation, while the fiscal year 2026 revenue figure of USD 15.8 billion provides the operating baseline. The market's next test is whether the expected fiscal year 2027 return to growth becomes visible in reported results.

CSL stock stays below its yearly high

CSL stock was trading at EUR 121.31 at Lang & Schwarz on October 20, 2026 at 4:40 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of CSL stock.